Publications in collaboration with researchers from Hospital Universitario de la Princesa (20)

2025

  1. Development and validation of a Delphi consensus-based questionnaire for the multidisciplinary management of type 2 inflammation-related diseases

    Frontiers in Allergy, Vol. 6

2024

  1. Multidisciplinary management of type 2 inflammation diseases using a screening tool

    Frontiers in Allergy, Vol. 5

2022

  1. First-in-human phase I clinical trial of a TLR4-binding DNA aptamer, ApTOLL: Safety and pharmacokinetics in healthy volunteers

    Molecular Therapy - Nucleic Acids, Vol. 28, pp. 124-135

  2. RICORS2040: The need for collaborative research in chronic kidney disease

    Clinical Kidney Journal, Vol. 15, Núm. 3, pp. 372-387

2020

  1. A quick flow cytometry protocol to assess Helicobacter pylori viability

    Journal of Microbiological Methods, Vol. 177

  2. Na+ controls hypoxic signalling by the mitochondrial respiratory chain

    Nature, Vol. 586, Núm. 7828, pp. 287-291

2019

  1. Rapid decrease in titer and breadth of neutralizing anti-HCV antibodies in HIV/HCV-coinfected patients who achieved SVR

    Scientific Reports, Vol. 9, Núm. 1

2016

  1. Activation of the orphan receptor GPR55 by lysophosphatidylinositol promotes metastasis in triple-negative breast cancer

    Oncotarget, Vol. 7, Núm. 30, pp. 47565-47575

2015

  1. Endocannabinoids drive the acquisition of an alternative phenotype in microglia

    Brain, Behavior, and Immunity, Vol. 49, pp. 233-245

  2. Fatty acid synthase is a metabolic marker of cell proliferation rather than malignancy in ovarian cancer and its precursor cells

    International Journal of Cancer, Vol. 136, Núm. 9, pp. 2078-2090

  3. Pleiotropic effects of cell wall amidase LytA on Streptococcus pneumoniae sensitivity to the host immune response

    Infection and Immunity, Vol. 83, Núm. 2, pp. 591-603

2014

  1. Tocilizumab en pacientes con artritis reumatoide activa y respuesta inadecuada a fármacos antirreumáticos modificadores de la enfermedad o antagonistas del factor de necrosis tumoral: Subanálisis de los datos españoles de un estudio abierto cercano a la práctica clínica habitual

    Reumatologia Clinica, Vol. 10, Núm. 2, pp. 94-100

2013

  1. Fungal extracellular ribotoxins as insecticidal agents

    Insect Biochemistry and Molecular Biology, Vol. 43, Núm. 1, pp. 39-46

  2. Helicobacter pylori inactivation and virulence gene damage using a supported sensitiser for photodynamic therapy

    European Journal of Medicinal Chemistry, Vol. 68, pp. 284-290

2012

  1. The Involvement of Thaumatin-Like Proteins in Plant Food Cross-Reactivity: A Multicenter Study Using a Specific Protein Microarray

    PLoS ONE, Vol. 7, Núm. 9

2011

  1. A polymorphism located at an ATG transcription start site of the heme oxygenase-2 gene is associated with classical Parkinson's disease

    Pharmacogenetics and Genomics, Vol. 21, Núm. 9, pp. 565-571

2010

  1. Signaling and biological effects of glucagon-like peptide 1 on the differentiation of mesenchymal stem cells from human bone marrow

    American Journal of Physiology - Endocrinology and Metabolism, Vol. 298, Núm. 3

2007

  1. The tetraspanin CD9 inhibits the proliferation and tumorigenicity of human colon carcinoma cells

    International Journal of Cancer, Vol. 121, Núm. 10, pp. 2140-2152

2006

  1. Severe Infections after Unrelated Donor Allogeneic Hematopoietic Stem Cell Transplantation in Adults: Comparison of Cord Blood Transplantation with Peripheral Blood and Bone Marrow Transplantation

    Biology of Blood and Marrow Transplantation, Vol. 12, Núm. 7, pp. 734-748

2003

  1. A functionally relevant conformational epitope on the CD9 tetraspanin depends on the association with activated β1 integrin

    Journal of Biological Chemistry, Vol. 278, Núm. 1, pp. 208-218